Results 31 to 40 of about 74,841 (314)

Botulinum toxin-A for the treatment of overactive bladder: UK contributions [PDF]

open access: yes, 2013
Background: Botulinum toxin-A (BoNT/A) is now established second-line management for refractory overactivebladder (OAB) and recognised in many incontinence guidelines and pathways.
Fowler, CJ   +13 more
core   +1 more source

The Structure and Classification of Botulinum Toxins

open access: yes, 2021
Botulinum neurotoxins (BoNTs) are a family of bacterial protein toxins produced by various Clostridium species. They are traditionally classified into seven major serotypes (BoNT/A-G).
Stenmark, Pål,   +2 more
core   +1 more source

Therapeutic Approach to Botulinum Injections for Hemifacial Spasm, Synkinesis and Blepharospasm

open access: yesToxins, 2022
The aim of this study was to show our therapeutic outcome of botulinum injection to the facial muscles and thereby to find the best therapeutic concept which should be embraced.
Gilad Yahalom   +3 more
doaj   +1 more source

Major pathogenic Clostridia in human and progress toward the clostridial vaccines [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2022
The Clostridium genus is composed of a large spectrum of heterogeneous bacteria. They are Gram-positive, mostly mesophilic, and anaerobic spore-forming strains. Clostridia are widely distributed in oxygen-free habitats.
Lida Abdolmohammadi Khiav   +1 more
doaj   +1 more source

Botulinum Toxin A for the Treatment of Keloids [PDF]

open access: yes, 2012
Introduction: Keloids are the result of excessive scar tissue formation. Besides their poor aesthetic appearance, keloids can be associated with severe clinical symptoms such as pain, itching, and rigidity.
Bureik, D.   +11 more
core   +1 more source

The Use of Botulinum Toxin in Medicine: Safety and Efficacy Based on the Latest Research

open access: yesJournal of Education, Health and Sport, 2023
Introduction and aim of the study: Botulinum toxin, produced by anaerobic bacteria of the Clostridium botulinum family, is one of the most potent organic compounds known to man. Despite its toxicity, it has found widespread use in medicine.
Anna Jaremek   +8 more
doaj   +1 more source

Use of botulinum toxin in aesthetic medicine and gynaecology: current approaches, controversies, and future directions

open access: yesMenopause Review, 2023
This review looks at the use of botulinum toxin in the gynaecological field with the aim of determining what needs to be further investigated to achieve a standardized application.
Andrea Etrusco   +5 more
doaj   +1 more source

Botulinum toxin type A for the management of glabellar rhytids [PDF]

open access: yes, 2010
Anne Marie Tremaine, Jerry L McCulloughDepartment of Dermatology, University of California, Irvine, CA, USAAbstract: There is an increasing demand for minimally-invasive cosmetic procedures to arrest the aging process.
Tremaine, Anne Marie   +3 more
core   +1 more source

Biosecurity Threat Posed by Botulinum Toxin

open access: yesToxins, 2019
The deliberate release of biological agents with terrorist or criminal intent continues to pose concerns in the current geopolitical situation. Therefore, attention is still needed to ensure preparedness against the potential use of pathogens as ...
Orlando Cenciarelli   +2 more
doaj   +1 more source

Diffusion of Botulinum Toxins

open access: yesTremor and Other Hyperkinetic Movements, 2012
Background: It is generally agreed that diffusion of botulinum toxin occurs, but the extent of the spread and its clinical importance are disputed. Many factors have been suggested to play a role but which have the most clinical relevance is a subject of much discussion.
Brodsky, Matthew A.   +2 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy